Galectin Therapeutics Inc. (GALT) Social Stream



Galectin Therapeutics Inc. (GALT): $3.37

0.01 (-0.30%)

POWR Rating

Component Grades

Momentum

D

Stability

C

Sentiment

Quality

C

Add GALT to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#158 of 362

in industry

GALECTIN THERAPEUTICS INC (GALT) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering GALECTIN THERAPEUTICS INC.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2022-04-01 1 $14 $14 $14 $1.9 636.84%
2023-11-14 1 $11 $11 $11 $1.9 478.95%

Price Target Last Issued November 14, 2023

The Trend in the Analyst Price Target


GALT's average price target has moved down $3 over the prior 27 months.

GALT reports an average of 519.43% for its upside potential over the past 33 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-03-31 1 11 11 11 2.10 423.81%
2023-05-17 1 11 11 11 1.67 558.68%
2023-08-15 1 11 11 11 1.60 587.5%
2023-11-14 1 11 11 11 1.81 507.73%

GALT Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 1 0 0 0 0 1

The Trend in the Broker Recommendations


GALT's average broker recommendation rating improved by 1 over the prior 25 months.

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • GALECTIN THERAPEUTICS INC's number of analysts covering the stock is greater than practically none of all US stocks.
  • GALT has a lower variance in analysts' estimates than nearly 100% of all US stocks.
  • In terms of how GALECTIN THERAPEUTICS INC fares relative to stocks in the small market cap category, note that its upside potential (average analyst target price relative to current price) is higher than 169.61% of that group.
  • To contextualize these metrics, consider that out of Healthcare stocks, GALECTIN THERAPEUTICS INC's average analyst price target is higher than 44.31% of them.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to GALECTIN THERAPEUTICS INC are ORIC, ANNX, and INZY.

Is GALT a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!